Abstract
BackgroundObstructive sleep apnea (OSA) is frequently seen with atrial fibrillation (AF) and is associated with increased cardiovascular morbidity, including hypertension, congestive heart failure, ischemic heart disease, and stroke. However, the impact of OSA on in-hospital outcomes of patients with AF is unclear.MethodologyAll patients aged ≥18 admitted primarily for AF between January 2016 and December 2017 were identified in the National Inpatient Sample database. They were then categorized into those with OSA and those without OSA. The primary outcome was in-hospital mortality. Unadjusted and adjusted analysis was performed on appropriate variables of interest.ResultsOf 156,521 primary AF hospitalizations, 15% of the patients had OSA. Baseline characteristics revealed no race disparity between the two groups. However, compared to those without OSA, the OSA group was younger and had a significantly higher proportion of males, obesity, heart failure, hypertension, chronic obstructive pulmonary disease, diabetes, and hyperlipidemia. Long-term anticoagulation and inpatient cardioversion were also higher in the OSA group. Following propensity matching, inpatient mortality was similar between the two groups [0.54% in OSA vs. 0.51% in non-OSA; adjusted odds ratio = 1.06 (95% confidence interval = 0.82-1.35)]. Similarly, OSA was not significantly associated with acute kidney injury, cardiac arrest, gastrointestinal bleed, acute stroke, or length of stay. However, the OSA group was less anemic and required fewer in-hospital blood transfusions.ConclusionsAlthough OSA is highly prevalent in AF patients, inpatient mortality and cardiovascular outcomes such as cardiac arrest, stroke, or major bleeding were similar in AF patients with or without concomitant OSA with no significant differences in length of stay.
Highlights
Atrial fibrillation (AF) is the most common sustained arrhythmia globally, with a higher incidence and prevalence reported in developed countries compared to developing countries [1,2]
Inpatient mortality was similar between the two groups [0.54% in Obstructive sleep apnea (OSA) vs. 0.51% in non-OSA; adjusted odds ratio = 1.06 (95% confidence interval = 0.82-1.35)]
OSA is highly prevalent in atrial fibrillation (AF) patients, inpatient mortality and cardiovascular outcomes such as cardiac arrest, stroke, or major bleeding were similar in AF patients with or without concomitant OSA with no significant differences in length of stay
Summary
Atrial fibrillation (AF) is the most common sustained arrhythmia globally, with a higher incidence and prevalence reported in developed countries compared to developing countries [1,2]. In the Multi-Ethnic Study of Atherosclerosis (MESA) study, the age- and sex-adjusted incidence rates per 1,000 person-years of AF were 11.2 among non-Hispanic whites compared to 6.1 among Hispanics, 5.8 among non-Hispanic blacks, and 3.9 among Asians [6]. Patients with AF are disproportionately affected by obstructive sleep apnea (OSA) than patients without AF, with the prevalence of OSA in AF patients estimated between 21% and 74% [1]. Obstructive sleep apnea (OSA) is frequently seen with atrial fibrillation (AF) and is associated with increased cardiovascular morbidity, including hypertension, congestive heart failure, ischemic heart disease, and stroke. The impact of OSA on in-hospital outcomes of patients with AF is unclear
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have